Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study.

NCI-CCC National Cancer Institute–designated Comprehensive Cancer Centers TBs cancer digital health health education health websites knowledge sharing oncology tumor boards

Journal

JMIR cancer
ISSN: 2369-1999
Titre abrégé: JMIR Cancer
Pays: Canada
ID NLM: 101666844

Informations de publication

Date de publication:
19 05 2022
Historique:
received: 27 09 2021
accepted: 17 03 2022
revised: 07 03 2022
entrez: 19 5 2022
pubmed: 20 5 2022
medline: 20 5 2022
Statut: epublish

Résumé

Expert knowledge is often shared among multidisciplinary academic teams at tumor boards (TBs) across the country, but these conversations exist in silos and do not reach the wider oncology community. Using an oncologist-only question and answer (Q&A) website, we sought to document expert insights from TBs at National Cancer Institute-designated Comprehensive Cancer Centers (NCI-CCCs) to provide educational benefits to the oncology community. We designed a process with the NCI-CCCs to document and share discussions from the TBs focused on areas of practice variation on theMednet, an interactive Q&A website of over 13,000 US oncologists. The faculty translated the TB discussions into concise, non-case-based Q&As on theMednet. Answers were peer reviewed and disseminated in email newsletters to registered oncologists. Reach and engagement were measured. Following each Q&A, a survey question asked how the TB Q&As impacted the readers' practice. A total of 23 breast, thoracic, gastrointestinal, and genitourinary programs from 16 NCI-CCC sites participated. Between December 2016 and July 2021, the faculty highlighted 368 questions from their TBs. Q&As were viewed 147,661 times by 7381 oncologists at 3515 institutions from all 50 states. A total of 277 (75%) Q&As were viewed every month. Of the 1063 responses to a survey question on how the Q&A affected clinicians' practices, 646 (61%) reported that it confirmed their current practice, 163 (20%) indicated that a Q&A would change their future practice, and 214 (15%) reported learning something new. Through an online Q&A platform, academics at the NCI-CCCs share knowledge outside the walls of academia with oncologists across the United States. Access to up-to-date expert knowledge can reassure clinicians' practices, significantly impact patient care in community practices, and be a source of new knowledge and education.

Sections du résumé

BACKGROUND
Expert knowledge is often shared among multidisciplinary academic teams at tumor boards (TBs) across the country, but these conversations exist in silos and do not reach the wider oncology community.
OBJECTIVE
Using an oncologist-only question and answer (Q&A) website, we sought to document expert insights from TBs at National Cancer Institute-designated Comprehensive Cancer Centers (NCI-CCCs) to provide educational benefits to the oncology community.
METHODS
We designed a process with the NCI-CCCs to document and share discussions from the TBs focused on areas of practice variation on theMednet, an interactive Q&A website of over 13,000 US oncologists. The faculty translated the TB discussions into concise, non-case-based Q&As on theMednet. Answers were peer reviewed and disseminated in email newsletters to registered oncologists. Reach and engagement were measured. Following each Q&A, a survey question asked how the TB Q&As impacted the readers' practice.
RESULTS
A total of 23 breast, thoracic, gastrointestinal, and genitourinary programs from 16 NCI-CCC sites participated. Between December 2016 and July 2021, the faculty highlighted 368 questions from their TBs. Q&As were viewed 147,661 times by 7381 oncologists at 3515 institutions from all 50 states. A total of 277 (75%) Q&As were viewed every month. Of the 1063 responses to a survey question on how the Q&A affected clinicians' practices, 646 (61%) reported that it confirmed their current practice, 163 (20%) indicated that a Q&A would change their future practice, and 214 (15%) reported learning something new.
CONCLUSIONS
Through an online Q&A platform, academics at the NCI-CCCs share knowledge outside the walls of academia with oncologists across the United States. Access to up-to-date expert knowledge can reassure clinicians' practices, significantly impact patient care in community practices, and be a source of new knowledge and education.

Identifiants

pubmed: 35588361
pii: v8i2e33859
doi: 10.2196/33859
pmc: PMC9164098
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e33859

Subventions

Organisme : NCI NIH HHS
ID : K08 CA255465
Pays : United States
Organisme : NCI NIH HHS
ID : K12 CA090625
Pays : United States
Organisme : NCI NIH HHS
ID : K12 CA215110
Pays : United States

Investigateurs

Hatem Soliman
Debasish Tripathy (D)
Dawn L Hershman (DL)
Gregory A Otterson (GA)
Bhuvaneswari Ramaswamy (B)
David Carbone (D)
Shadia Jalal (S)
Hanna Nasser (H)
Kevin Kalinsky (K)
Amye Tevaarwerk (A)
Carlos H Barcenas (CH)
Wisinski Kari (W)
Maryam Lustberg (M)
Leora Horn (L)
Katherine D Crew (KD)
Dwight H Owen (DH)
Bora Lim (B)
Banu Arun (B)
Parvin Peddi (P)
Jill Lacy (J)
Paul R Helft (PR)
Shirish Gadgeel (S)
N Lynn Henry (NL)
Saundra S Buys (SS)
Anne Chiang (A)
Naoto Ueno (N)

Informations de copyright

©Maitri Kalra, Elizabeth Henry, Kelly McCann, Meghan S Karuturi, Jean G Bustamante Alvarez, Amanda Parkes, Robert Wesolowski, Mei Wei, Sarah S Mougalian, Gregory Durm, Angel Qin, Caitlin Schonewolf, Meghna Trivedi, Avan J Armaghani, Frederick H Wilson, Wade T Iams, Anita A Turk, Praveen Vikas, Michael Cecchini, Sam Lubner, Priyadarshini Pathak, Kristen Spencer, Vadim S Koshkin, Matthew K Labriola, Catherine H Marshall, Katy E Beckermann, theMednet.org NCI-CCC Tumor Board Program Collaborative Group, Marina N Sharifi, Anthony C Bejjani, Varsha Hotchandani, Samir Housri, Nadine Housri. Originally published in JMIR Cancer (https://cancer.jmir.org), 19.05.2022.

Références

JAMA Intern Med. 2013 Nov 25;173(21):1962-9
pubmed: 23979118
CA Cancer J Clin. 2016 Jul;66(4):337-50
pubmed: 26891458
JAMA Oncol. 2015 Dec;1(9):1303-10
pubmed: 26448610
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
JAMA Intern Med. 2014 May;174(5):710-8
pubmed: 24663331
Cancer. 2006 Oct 15;107(8 Suppl):1980-6
pubmed: 16929483
J Cancer Educ. 2008;23(4):235-7
pubmed: 19058072
J Am Coll Surg. 2015 May;220(5):940-50
pubmed: 25840536
J Am Med Inform Assoc. 2007 Jul-Aug;14(4):407-14
pubmed: 17460122
J Natl Cancer Inst. 2015 Apr 11;107(7):
pubmed: 25863335
BMJ. 1996 Oct 26;313(7064):1062-8
pubmed: 8898602
J Registry Manag. 2011 Winter;38(4):209-11
pubmed: 23270096
J Contin Educ Health Prof. 2006 Spring;26(2):120-7
pubmed: 16802313

Auteurs

Maitri Kalra (M)

Division of Hematology/Oncology, Department of Medicine, Indiana University Health Ball Memorial Hospital, Fishers, IN, United States.

Elizabeth Henry (E)

Division of Hematology/Oncology, Department of Medicine, Loyola University Stritch School of Medicine, Maywood, IL, United States.

Kelly McCann (K)

Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, Beverly Hills, CA, United States.

Meghan S Karuturi (MS)

Division of Hematology/Oncology, Department of Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Jean G Bustamante Alvarez (JG)

Division of Hematology/Oncology, Department of Medicine, West Virginia University, Morgantown, WV, United States.

Amanda Parkes (A)

Division of Hematology/Oncology, Department of Medicine, University of Wisconsin, Madison, WI, United States.

Robert Wesolowski (R)

Division of Hematology/Oncology, Department of Medicine, Ohio State University, Columbus, OH, United States.

Mei Wei (M)

Division of Hematology/Oncology, Department of Medicine, University of Utah, Utah City, UT, United States.

Sarah S Mougalian (SS)

Department of Radiation/Oncology, Yale University School of Medicine, New Haven, CT, United States.

Gregory Durm (G)

Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.

Angel Qin (A)

Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, United States.

Caitlin Schonewolf (C)

Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, United States.

Meghna Trivedi (M)

Division of Hematology/Oncology, Department of Medicine, Herbert-Irving Comprehensive Cancer Center, Columbia University, New York, NY, United States.

Avan J Armaghani (AJ)

Division of Hematology/Oncology, Department of Medicine, Moffitt Cancer Center University of South Florida, Tampa, FL, United States.

Frederick H Wilson (FH)

Department of Radiation/Oncology, Yale University School of Medicine, New Haven, CT, United States.

Wade T Iams (WT)

Division of Oncology, Department of Medicine, Vanderbilt University, Nashville, TN, United States.

Anita A Turk (AA)

Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.

Praveen Vikas (P)

Division of Hematology/Oncology, Department of Medicine, University of Iowa, Iowa City, IA, United States.

Michael Cecchini (M)

Department of Radiation/Oncology, Yale University School of Medicine, New Haven, CT, United States.

Sam Lubner (S)

Division of Hematology/Oncology, Department of Medicine, University of Wisconsin, Madison, WI, United States.

Priyadarshini Pathak (P)

Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.

Kristen Spencer (K)

Division of Hematology/Oncology, Department of Medicine, Rutgers University Cancer Institute of New Jersey, New Brunswick, NJ, United States.

Vadim S Koshkin (VS)

Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, Beverly Hills, CA, United States.

Matthew K Labriola (MK)

Division of Hematology/Oncology, Department of Medicine, Duke University, Durham, NC, United States.

Catherine H Marshall (CH)

Division of Oncology, Department of Medicine, Johns Hopkins University, Baltimore, MD, United States.

Katy E Beckermann (KE)

Division of Oncology, Department of Medicine, Vanderbilt University, Nashville, TN, United States.
Mednet Inc, New York, NY, United States.

Marina N Sharifi (MN)

Division of Hematology/Oncology, Department of Medicine, University of Wisconsin, Madison, WI, United States.

Anthony C Bejjani (AC)

Division of Hematology/Oncology, Department of Medicine, Veterans Health Administration Greater Los Angeles Health System, Los Angeles, CA, United States.

Varsha Hotchandani (V)

Mednet Inc, New York, NY, United States.

Samir Housri (S)

Mednet Inc, New York, NY, United States.

Nadine Housri (N)

Department of Radiation/Oncology, Yale University School of Medicine, New Haven, CT, United States.

Classifications MeSH